215
Views
15
CrossRef citations to date
0
Altmetric
Review Article

Thromboprophylaxis in hip arthroplasty: New frontiers and future strategy

Pages 339-342 | Received 14 Feb 1998, Accepted 17 Apr 1998, Published online: 08 Jul 2009

References

  • Agnelli G, Ranucci V, Veschi F, Rinonapoli E, Lupattelli L, Nen-Ci G G. Clinical outcome of orthopaedic patients with negative lower limb venography at discharge. Thromb Haemost 1995; 74: 1042–4
  • Andreassen G, Dahl O E. Tidlig dyp venøs trombose etter hofteledds kirurgi er ikke tilgjengelig for klinisk diagnostikk. TidsskrNorLægeforen 1997; 14: 2026–7
  • Bergqvist D, Benoni G, Bjorgell O, Fredin H, Hedlundh U, Nicolas S, Nilsson P, Nylander G. Low-molecular-weight heparin (enoxaparin) as prophylaxis against venous thromboembolism after total hip replacement. N Engl J Med 1996; 335: 696–700
  • Campling E A, Devlin H B, Hoile R W, Lunn J N. The report of the National Confidential Enquiry into Perioperative Deaths 1991/92. Published by National Confidential Enquiry into Peri-Operative Deaths (NCEPOD), LondonEngland 1993
  • Campling E A, Devlin H B, Hoile R W, Lunn J N. The report of the National Confidential Enquiry into Perioperative Deaths 1992/93. Published by National Confidential Enquiry into Peri-operative Deaths (NCEPOD), LondonEngland 1994
  • Clarke M T, Green J S, Harper W M, Gregg P J. Screening for deep-venous thrombosis after hip and knee replacement surgery. J Bone Joint Surg (Br) 1997; 79(5)787–91
  • Cohen M, Demers C, Gurfinkel E P, Turpie A G G, Fromell G J, Goodman S, Langer A, Califf R M, Fox K A A, Premmereur J, Bigonzi F. A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. N Engl J Med 1997; 337: 447–52
  • Dahl O E. Cardiorespiratory and vascular dysfunction related to major reconstructive orthopedic surgery. Acta Orthop Scand 1997a; 68: 607–14
  • Dahl O E. Effects of hip replacement surgery on the haemostatic system. Thesis, University of Oslo, Norway 1997
  • Dahl O E, Molnar I, Vinje A, Rø J S, Kierulf P, Andersen A W, Dalaker K, Prydz H. Studies on coagulation, fibrinolysis, kal-likrein-kinin and complement activation in systemic and pulmonary circulation during hip arthroplasty with acrylic cement. Thromb Res 1988; 50: 875–84
  • Dahl O E, Johnsen H, Kierulf P, Molnar I, Rø J S, Vinje A, Mowinckel P. Intrapulmonary thrombin generation and its relation to monomethyl- methacrylate plasma levels during hip arthroplasty. Acta Anaesthesiol Scand 1992; 36: 331–5
  • Dahl O E, Pedersen T, Kierulf P, Westvik Å-B, Lund P, Arnesen H, Seljeflot I, Abdelnoor M, Lyberg T. Sequential intrapulmo-nary and systemic activation of coagulation and fibrinolysis during and after total hip replacement. Thromb Res 1993; 70: 451–8
  • Dahl O E, Aspelin T, Arnesen H, Seljeflot I, Kierulf P, Ruyter R, Lyberg T. Increased activation of coagulation and formation of late deep venous thrombosis following discontinuation of thromboprophylaxis after hip replacement surgery. Thromb Res 1995; 80: 299–306
  • Dahl O E, Andreassen G, Aspelin T, Muller C, Mathiesen P, Ny-Hus S, Abdelnoor M, Solhaug J-H, Arnesen H. Prolonged thromboprophylaxis following hip replacement surgery. Thromb Haemost 1997; 1: 26–31
  • Fender D, Harper W M, Thompson J R, Gregg P J. Mortality and fatal pulmonary embolism after primary total hip replacement. J Bone J Surg (Br) 1997; 79: 896–9
  • Gallino A, Haeberli A, Hess T, Mobelli G, Straub P W. Fibrin formation and platelet aggregation in patients with acute myocardial infarction: effects of intravenous and subcutaneous low-dose heparin. Am Heart J 1986; 112: 285–90
  • Gold H K, Torres F W, Garabedian H D, Werner W, Jang I K, Khan A, Hagstrom J N, Yasuda T, Leinbach R C, Newell J B. Evidence for a rebound coagulation phenomenon after cessation of a 4-hour infusion of a specific thrombin inhibitor in patients with unstable angina pectoris. J Am Coll Cardiol 1993; 21: 1039–47
  • Granger C B, Miller J M, Bovill E G, Gruber A, Tracy R P, Kru-Coff M W, Green C, Berrios E, Harrington R A, Ohman E M. Rebound increase in thrombin generation and activity after cessation of intravenous heparin in patients with acute coronary syndromes. Circulation 1995; 1: 1929–35
  • Havelin L I, Furnes O, Lie S A. 1996, Rapport 1996 Nasjonalt Register for Leddproteser. Ortopedisk avdeling, Haukeland Syke-hus
  • Havig Ø. Deep vein thrombosis. Thesis, University of Oslo, Norway 1977
  • Johnson R, Green J R, Charnley J. Pulmonary embolism and its prophylaxis folowing the Charnley total hip replacement. Clin Orthop 1977; 127: 123–32
  • Karwinsky B. The significance of autopsy in modern medicine. A study from western Norway. Thesis, University of Bergen, Norway 1995
  • Lassen M, Borris L. on behalf of the Danish Prolonged Prophylaxis Study Group: Prolonged thromboprophylaxis with low-molecular-weight heparin (Fragmin) after elective total hip arthroplasty. A placebo-controlled study. Thromb Haemost 1995; 6: 781
  • Malchau H, Herberts P. Prognosen vid total hoftartroplastik. The National Hip Arthroplasty Register. Sweden 1996
  • McNally M A, Molland R A B. Total hip replacement, lower limb blood flow and venous thrombogenesis. J Bone Joint Surg (Br) 1993; 75: 640–4
  • McNally M A, Cooke E A, Mollan R A B. The effect of active flow movement of the foot on venous blood flow after total hip replacement. J Bone Joint Surg (Am) 1997; 7: 1198–201
  • Merlini P A, Ardissino D. Current status of activation markers in ischemic heart disease: markers of coagulation activation. Thromb Haemost 1997; 78: 276–9
  • Murray D W, Britton A R, Bulstrode C J. Thromboprophylaxis and death after total hip replacement. J Bone Joint Surg (Br) 1996; 78: 863–70
  • Planes A, Vochelle N, Darmon J Y, Fagola M, Bellaud M, Huet Y. Risk of deep-venous thrombosis after hospital discharge in patients having undergone total hip replacement: double-blind randomised comparison enoxaparin versus placebo. Lancet 1996; 348: 224–8
  • Sandler D A, Martin J F. Autopsy-proven pulmonary embolism in hospital patients: are we detecting enough deep vein thrombosis?. J Roy Soc Med 1989; 82: 203–5
  • Schöning B, Schulitz K P, Pfluger T. Statistical analysis of perioperative and postoperative mortality of patients with prosthetic replacement of the hip. Arch Orthop Traumat Surg 1980; 97: 21–6
  • Seagroatt U, Tan H S, Goldrace M, Bulstrode C, Nugent I, Gill L. Elective total hip replacement: Incidence, emergency read-mission rate and postoperative mortality. BMJ 1991; 303: 1431–5
  • Stewart G J, Alburger P D, Stone E A, Soszka T W. Total hip replacement induces injury to remote veins in a canine model. J Bone Joint Surg (Am) 1983; 65: 97–102
  • Wallentin L and the FRISC study group. Low-molecular-weight heparin during instability in coronary artery disease. Lancet 1996; 347: 561–8
  • Warwick D J, Whitehouse S. Symptomatic venous thromboembolism after total knee replacement. J Bone Joint Surg (Br) 1997; 79: 780–6
  • Wells P S, Hirsh J, Anderson D R, Lensing A W, Foster G, Kearon C, Weitz J, ĎOvidio R, Cogo A, Prandoni P. Accuracy of clinical assessment of deep-vein thrombosis. Lancet 1995; 345: 1326–30
  • Woo R, Minster G J, Fitzgerald R H, Mason L D, Lucas D R, Smith F E. Pulmonary fat embolism in revision hip arthroplasty. Clin Orthop 1995; 319: 41–53

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.